SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is seeing intense volatility as market participants debate whether the massive, sustained price surge is an organic short squeeze or extreme institutional manipulation. The community is actively discussing the high concentration of shares held by major hedge funds, the lack of available shares to borrow, and the heightened risk of a sharp mean reversion as traders compare the setup to historical squeeze events.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors focus on the company's strategic acquisition of Northern Data and significant financial backing from Tether, fueling speculation about its potential as a major player in the AI cloud infrastructure space. The community is heavily focused on the stock's elevated short interest, with many traders discussing the setup for a potential short squeeze alongside growing institutional interest.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is surging as investors react to a new executive order prioritizing the development and review of psychedelic medicines, including ibogaine. The community is heavily focused on the stock's low float and high potential for a short squeeze, while also debating the firm's long-term regulatory prospects versus its current volatility.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as community members highlight a significant uptick in institutional and insider activity, alongside recent regulatory milestones like the FCA approval of its Shackleton Finance acquisition. Investors are increasingly optimistic about the company's long-term AI infrastructure pipeline, particularly the Yotta partnership in India, while debating the stock's volatility and the potential for a technical breakout.

Maase, Inc. engages in the provision of intelligent technology-driven family and enterprise services. It operates through the following business segments: Insurance Agency and Wealth Management. The Insurance Agency segment involves in providing agency services for distributing life and non-life insurance products on behalf of insurance companies. The Wealth Management segment offers financial advisory, investment planning, and asset management services for individuals, families, and corporate clients, utilizing data-driven insights and digital platforms to optimize financial outcomes. The company was founded by Hai Feng Yu on August 6, 2018, and is headquartered in Guangzhou, China.

Maase Inc. - Ordinary Shares - Class A

Highest Performances Holdings Inc. - ADR

MAAS is trending as traders speculate on a potential technical breakout driven by low-float dynamics and aggressive acquisition activity in the AI and healthcare sectors. The community is actively debating whether the stock serves as a high-upside infrastructure play or a high-risk speculative vehicle, with sentiment divided between those chasing the recent momentum and those wary of past dilution history.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending due to a newly announced collaboration with NVIDIA that integrates its QNX safety-critical OS into advanced edge AI systems across automotive, robotics, and industrial sectors. The community is actively discussing this as a major fundamental catalyst, with many investors anticipating a significant long-term revaluation driven by growth in physical AI and enterprise demand for secure operating systems.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing a significant surge in momentum as the stock breaks past a long-term downtrend, fueled by continued aggressive Bitcoin accumulation and the announcement of a new semi-monthly dividend structure for its preferred shares. Market participants are actively debating the sustainability of this rally, with bulls highlighting the stock's role as a levered proxy for Bitcoin's upward movement, while shorts remain under intense pressure amid a sharp increase in trading volume.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending following the release of statistically significant Phase 3 trial results for its COMP360 psilocybin therapy, alongside a broader market rally in the psychedelic biotech sector fueled by a presidential executive order aimed at accelerating psychedelic research and FDA review pathways. While the community is actively debating the significance of the trial data, the potential for priority review vouchers, and the possibility of future M&A activity, traders are closely monitoring liquidity and volatility as the stock reacts to these major clinical and policy catalysts.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing increased investor activity driven by speculation over a potential buyout following recent consolidation in the biotech sector and significant capital infusion from Blue Owl. The community is focused on the company's Briumvi growth trajectory and the upcoming clinical data for its subcutaneous administration and Azer-cel pipeline, which many believe makes the stock an attractive target for larger pharmaceutical firms.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is currently trending as investors debate the impact of the company's recent rebranding and leadership changes alongside upcoming clinical data. The community is actively discussing the stock's potential as a buyout candidate and debating the significance of the Phase 2 generalized anxiety disorder data readout, with some expressing skepticism over past performance and leadership churn.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Microbot Medical Begins Full U.S. Launch of LIBERTY System

MBOT moves to full U.S. launch of its LIBERTY robotic system after strong hospital adoption, boosting momentum for faster market uptake and sales growth.

Microbot Medical's (MBOT) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright restated a "buy" rating and issued a $12.00 target price on shares of Microbot Medical in a report on Tuesday...

Microbot Medical (NASDAQ:MBOT) Shares Pass Above 200-Day Moving Average - Time to Sell?

Microbot Medical (NASDAQ:MBOT) Stock Passes Above 200-Day Moving Average - Should You Sell...

Microbot Medical Inc. (NASDAQ:MBOT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Microbot Medical Inc. (NASDAQ:MBOT - Get Free Report) have been given an average rating of "Moderate Buy" by the five research firms that are currently covering the firm, MarketBeat...

Microbot Medical (NASDAQ:MBOT) Announces Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Microbot Medical (NASDAQ:MBOT - Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported ($0.04) EPS for the quarter, topping analysts' consensus...

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value PR Newswire VANCOUVER, BC, March 27, 2026 Issued on behalf of...

Microbot Medical Inc. $MBOT Shares Purchased by CIBC Private Wealth Group LLC

CIBC Private Wealth Group LLC raised its position in Microbot Medical Inc. (NASDAQ:MBOT - Free Report) by 137.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,454,000 shares of the biotechnology company's stock aft...

Heights Capital Management Inc. Buys New Stake in Microbot Medical Inc. $MBOT

Heights Capital Management Inc. bought a new stake in shares of Microbot Medical Inc. (NASDAQ:MBOT - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with...

Microbot Medical (NASDAQ:MBOT) Stock Price Crosses Above 200-Day Moving Average - Here's What Happened

Microbot Medical (NASDAQ:MBOT) Shares Cross Above Two Hundred Day Moving Average - Here's Why...

Microbot Medical (MBOT) to Release Earnings on Tuesday

Microbot Medical (NASDAQ:MBOT) will be releasing earnings before the market opens on Tuesday, March 24. (View Earnings Report at...

Microbot Medical, Inc. is a medical device company, which engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

MBOT
Microbot Medical Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MBOT News

MBOTMicrobot Medical Inc